stiripentol has been researched along with Nephrolithiasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Drüeke, TB; Wyatt, CM | 1 |
| Baud, L; Bouderlique, E; Chemaly, N; Daudon, M; Deschênes, G; Frochot, V; Haymann, JP; Huguet, L; Le Dudal, M; Letavernier, E; Martori, C; Nabbout, R; Perez, J; Tang, E; Vandermeersch, S | 1 |
| Assimos, DG | 1 |
3 other study(ies) available for stiripentol and Nephrolithiasis
| Article | Year |
|---|---|
Stiripentol for the treatment of primary hyperoxaluria and calcium oxalate nephropathy.
Topics: Calcium; Calcium Oxalate; Dioxolanes; Ethylene Glycols; Humans; Hyperoxaluria; Hyperoxaluria, Primary; Nephrolithiasis | 2020 |
Stiripentol protects against calcium oxalate nephrolithiasis and ethylene glycol poisoning.
Topics: Animals; Calcium Oxalate; Dioxolanes; Epilepsies, Myoclonic; Ethylene Glycol; Female; Hepatocytes; Humans; Hyperoxaluria, Primary; Kidney; Male; Nephrolithiasis; Rats; Rats, Sprague-Dawley | 2019 |
Re: Stiripentol Protects against Calcium Oxalate Nephrolithiasis and Ethylene Glycol Poisoning.
Topics: Calcium Oxalate; Dioxolanes; Ethylene Glycols; Humans; Nephrolithiasis | 2019 |